NovaQuest Capital Management: Funding, Team & Investors | Startup Intros

Loading organizations...

NovaQuest Capital Management: Funding, Team & Investors | Startup Intros

Financial History

Total Raised

N/A

Valuation

N/A

Investments Made

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Jun 30, 2025	Gallant	$18.0M Series B	Cindy Cole	Teymour Boutros-Ghali, Hill Creek Partners, Brian A.
May 1, 2022	TARGAN	$35.0M Series C	Mountain Group Partners, Brian A.	Stephen Murray, Justin Wright-Eakes
May 1, 2020	Arvelle Therapeutics	$43.0M Series A	—	Andera Partners, BRV Capital Management, F-Prime Capital, H.I.G. BioHealth Partners, KB Investment, LSP, Matt Bullard
Feb 1, 2019	Arvelle Therapeutics	$180.0M Series A	—	Andera Partners, BRV Capital Management, H.I.G. BioHealth Partners, martijn kleijwegt
Apr 2, 2013	Revance Therapeutics	$104.0M Other Equity / Series E	—	Bio*One Capital, Delphi Ventures, Pac-Link Ventures, Palo Alto Investors, Shepherd Ventures, Technology Partners, Vivo Ventures
Jun 10, 2011	Ambit Pharmaceuticals	$30.0M Series D	Allan Marchington	Forward Ventures, Genechem, Gimv, GrowthWorks, Horizon Technology Finance, MedImmune Ventures, OrbiMed, Perseus-Soros Biopharmaceutical Fund, Radius Ventures, Roche
Jun 10, 2011	Revance Therapeutics	$45.0M Other Equity	Jonathan Tunnicliffe	CNF Investments, Essex Capital Corporation, Pac-Link Ventures, Palo Alto Investors, Shepherd Ventures, Technology Partners, Vivo Ventures
Nov 1, 2007	Ambit Biosciences	$49.0M Series D	—	OrbiMed, Allan Marchington, Avalon Ventures, Standish Fleming, Genechem, Gimv, Horizon Technology Finance, Jov-CMDF, David Mott, Perseus-Soros Biopharmaceutical Fund, Radius Ventures, Roche